ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ALDX vs DWTX // RETURN ON INVESTED CAPITAL (ROIC)

Aldeyra Therapeutics Inc. (NASDAQ) VS. Dogwood Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: ALDX 1 — DWTX 3
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: DWTX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALDX VS. DWTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ALDX DWTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -32.30% -2.70 DWTX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 ALDX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 24.4 44.1 -19.61 DWTX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $39.8M $41.8M -$2.0M DWTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ALDX REV DWTX REV ALDX GROSS % DWTX GROSS % ALDX FCF DWTX FCF
FY 2025 $0 $0 — — -$33.3M -$15.6M
FY 2024 $0 $0 — — -$43.2M -$8.8M
FY 2023 $0 $0 — — -$30.3M -$4.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALDX // BETA —
DWTX // BETA —